China News Agency, Beijing, October 15th. "Medical Device Blue Book: China's Medical Device Industry Development Report (2021)" was released in Beijing on the 15th.

The Blue Book pointed out that China's medical device industry has played an important role in the prevention and control of the new crown pneumonia epidemic, and the export of medical devices, especially those used for the prevention and control of the new crown pneumonia epidemic, has increased significantly.

  This is the fifth medical device blue book released by China since 2017, which was written by nearly a hundred industry experts.

The Blue Book summarizes the development status of China's medical device industry and some subdivisions, and proposes the future development direction of the industry.

  According to the blue book, the new crown pneumonia epidemic hit in early 2020, and the drug supervision and administration departments at all levels promptly initiated the emergency review and approval procedures, racing against time to carry out emergency approval.

According to the actual situation of the most urgent need for new coronavirus detection reagents, on January 22, 2020, it is determined that 8 new coronavirus detection reagents will be included in the emergency approval. On the 26th of the same month, 4 detection reagents are approved for listing, so as to timely confirm the new coronary pneumonia patients and suspicious people. Screening provides a powerful tool.

  The blue book stated that as of the end of 2020, China National Medical Products Administration and relevant provincial drug regulatory authorities have successively reviewed and approved 54 new coronavirus detection reagents, with a daily production capacity of more than 24 million copies; emergency review and review approved the registration of medical protective clothing There are 423 certificates, with a maximum daily production capacity of 2.95 million sets; emergency review and approval of 308 medical protective mask registration certificates, with a maximum daily production capacity of 21.14 million sets.

  At the same time, the emergency review and approval of products needed for the treatment of patients with new coronary pneumonia, such as ventilators, thermometers, and infusion devices, are actively promoted.

The safety and effectiveness of China's new crown pneumonia epidemic prevention and control supplies and the production and supply capacity have been verified.

The Blue Book stated that the medical device industry has played an important role in the prevention and control of the new crown pneumonia epidemic and has played an irreplaceable role.

  In addition, the Blue Book pointed out that in 2020 China's medical device exports, especially those used for the prevention and control of the new crown pneumonia epidemic, will increase significantly, supporting the prevention and control of the new crown pneumonia epidemic in relevant countries and regions and even the world.

  According to statistics from the China Medical Insurance Chamber of Commerce, China's medical equipment (including epidemic prevention materials) import and export trade volume reached 103.72 billion U.S. dollars in 2020, of which medical equipment (including epidemic prevention materials) exported approximately 73.204 billion U.S. dollars, an increase of 72.59% year-on-year.

Among China's exports in 2020, the total value of anti-epidemic materials exports reached 438.5 billion yuan, of which 224.2 billion masks were exported, which is equivalent to providing nearly 40 masks for everyone in the world except China.

  According to the Blue Book, China also exported 2.31 billion pieces of protective clothing, 289 million pairs of goggles, 271,000 ventilators, and 1.08 billion copies of new coronavirus detection kits.

The export of products directly related to the anti-epidemic, such as infrared human thermometers, diagnostic reagents, gloves, patient monitors and other products, has achieved explosive growth.

  The Blue Book also pointed out that the main reason for the significant increase in China's medical device exports is that when many countries' industrial chains and supply chains have been severely damaged or even shut down, China's industrial system has taken the lead to resume normal operations, and the competitive advantage of exports has become more prominent.

(over)